Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Prepublished online as a Blood First Edition Paper on June 7, 2002; DOI 10.1182/blood-2002-04-1186.

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2002-04-1186v1
100/7/2403    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tormene, D.
Right arrow Articles by Girolami, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tormene, D.
Right arrow Articles by Girolami, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted April 22, 2002
Accepted May 23, 2002

The incidence of venous thromboembolism in thrombophilic children: a prospective cohort study

Daniela Tormene, Paolo Simioni, Paolo Prandoni*, Francesca Franz, Patrizia Zerbinati, Giulio Tognin, and Antonio Girolami

Medical and Surgical Sciences, University of Padua, Padua, Italy

* Corresponding author; email: paoprand{at}tin.it.

Antithrombin, protein C and S defects, Factor V Leiden and G20210A prothrombin gene mutation are well recognized risk factors for venous thromboembolism (VTE) in adults, especially during circumstantial situations such as trauma, immobilization, surgery, or oral contraceptive treatment. The relevance of these defects in predisposing children to VTE is still undefined. In a prospective cohort study we assessed the incidence of spontaneous and risk period-related VTE in asymptomatic children (aged 1 to 14 years), who were family members of a proband with an objectively diagnosed VTE event and a documented single thrombophilic abnormality. We enrolled 143 children from 63 families. Of them, 81 (56.6%) were carriers of an inherited defect, while the remaining 62 were free from thrombophilia. The mean observation period was five years (range, 1 to 8 years) in each group. Thirty-one risk periods occurred in the carriers group, and 20 in non-carriers. Neither spontaneous nor risk period- related VTE occurred in either group during 395 and 296 observation years, respectively. However, circumstances where most of the pediatric thromboses occur (insertion of central venous lines, cancer, and cardiovascular surgery) were not encountered. In conclusion, the thrombotic risk in otherwise healthy children with a single identified thrombophilic defect appears to be very low. Common triggering conditions for VTE in thrombophilic adults do not seem to increase the thrombotic risk in children carrying the same inherited defect. Accordingly, screening for thrombophilia in otherwise healthy children younger than 15 years, belonging to families with inherited defects predisposing to thrombosis, seems unjustified.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Journal of Pediatric Oncology NursingHome page
J. A. Connor
Factor V Leiden and Its Effect on Children With Cardiac Pathology
Journal of Pediatric Oncology Nursing, May 1, 2005; 22(3): 176 - 181.
[Abstract] [PDF]


Home page
CLIN PEDIATRHome page
M. J. Beck and B. Berman
Review of Thrombophilic States
Clinical Pediatrics, April 1, 2005; 44(3): 193 - 199.
[PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
Sponsor: Genentech BioOncology and and Biogen Idec
Blood Online is supported in part by
Genentech BioOncology and Biogen Idec
  Copyright © 2002 by American Society of Hematology         Online ISSN: 1528-0020